MICHELLE CARTER: Open Payments
NPI 1114015302 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$296 in 3 payments from 3 companies in 2025. Trend: 2023 $144 · 2024 $327 · 2025 $296
Food & beverage: $296
| Company | Payments | Amount |
|---|---|---|
| Luye Pharma (USA) Ltd. | 1 | $130 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| Novo Nordisk Inc | 1 | $42 |
Products named: ERZOFRI EXTENDED-RELEASE, ABILIFY MAINTENA, Wegovy.
Industry payments across IN — which companies pay providers there.
